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Background: Although the total number of new documented HIV diagnoses annually 
decreased from 2008-2018, the rate of decrease started to slow in 2013, and substantial 
variation exists across at-risk groups. People who inject drugs (PWID) account for 9% of 
new diagnoses annually, with increasing incidence in this population starting in 2015. 
Among PWID, 34% of new HIV diagnoses occurred in individuals who were also 
classified as men who have sex with men (MSM), indicating that MSM-PWID have 
elevated HIV risk. Data on MSM-PWID are scarce, and programmatic and advocacy 
efforts in HIV prevention do not specifically target MSM-PWID, with no CDC-
recommended interventions existing for this population.  
Objective: We sought to characterize the complex, intersecting and unique HIV risks 
faced by MSM-PWID, including perceptions of HIV risk and attitudes toward 
antiretroviral pre-exposure prophylaxis (PrEP) among MSM-PWID in urban and non-
urban areas of Massachusetts and Rhode Island. 
Methods: We recruited PWID through community-based organizations (CBOs; e.g. 
syringe service programs) in 18 urban centers and smaller cities and towns across 
Massachusetts and Rhode Island. Participants completed semi-structured interviews 
exploring substance use behaviors and HIV prevention needs. This in-depth analysis 
	
	 vi	
focused on describing the experiences and HIV prevention needs and attitudes of nine 
participants in the sample who reported a sexual orientation other than “heterosexual.”  
Results: Most participants identified as cisgender, bisexual men. However, the context of 
their sexual behaviors varied, with some participants only engaging in same-sex behavior 
during sex work. The relationship between identity and behavior is explored in the 
context of reported risk behavior. All participants engaged in at least one behavior that 
increased risk of HIV acquisition, including syringe sharing, inconsistent condom use, 
and sex work. Participants also described heightened risk when these behaviors 
overlapped, particularly within contexts of “sex parties” that some individuals described. 
At the same time, experiences of isolation and exclusion were common in the sample, 
indicating a potential vulnerability in this population. HIV risk perception varied among 
participants, but was not consistently aligned with the behaviors described. Many 
participants did not perceive needing HIV prevention services “yet,” indicating that they 
did not view their risk to be high enough to warrant prevention services. Alternatively, 
some described needing to prioritize daily survival and mental health over HIV 
prevention efforts. Although knowledge of PrEP was low, acceptability of PrEP was high 
in this sample, and several participants provided specific suggestions for improving the 
feasibility of PrEP. 
Conclusion: Data from this study illustrate the HIV risks and prevention needs of this at-
risk population and highlight mechanisms to engage them in preventative care. Our main 
findings are (1) participants had low knowledge of PrEP, but were largely enthusiastic 
after learning about it from interviewers, (2) varying identity related to same-sex 
	
	 vii	
behavior among men who have sex with men and inject drugs may play a role in shaping 
HIV risk and prevention needs, (3) specific healthcare and prevention service needs of 
this population emerged, including reducing risk at sex parties and improving access to 
non-stigmatizing mental health services. An in-depth understanding of the ways in which 
sexual orientation and gender identity shape HIV risk and prevention needs remains 
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People who inject drugs (PWID) are disproportionately affected by human 
immunodeficiency virus (HIV), accounting for approximately 9% of new diagnoses 
annually.1 PWID represent a key population needing more attention within HIV 
prevention efforts, as exemplified by the recent HIV outbreaks attributed to injection 
drug use in Scott County, Indiana (2014-15)2; Lawrence and Lowell, Massachusetts 
(2015-18)3; King County, Washington (2017-18)4; and Cabell County, West Virginia 
(2018-19)5. Among PWID, 34% of new HIV diagnoses occurred in individuals who were 
also classified as men who have sex with men (MSM).1 This suggests that MSM carry 
not only the largest burden compared to any other group in the United States—70% of 
new HIV diagnoses in 20176—but also a disproportionate burden within the community 
of PWID. The total number of new HIV cases is also likely much higher than reported, as 
approximately 14.5% of the population are estimated to have undiagnosed infections and 
account for 40% of transmissions nationally.7 
 
Although the total number of new documented HIV diagnoses annually was 
decreasing nationally from 2008-2018, the rate of decrease started to slow in 2013, and 
substantial variation exists across at-risk groups (Figure 1).8 Among MSM, the rate of 
new HIV infections has remained stable at roughly 26,000 new infections per year. In 
PWID, the new infections decreased by 44% over a decade, but have begun to increase in 
recent years, following a persistent uptick in cases starting in 2015.9  
 
	
Figure 1: HIV diagnoses among all transmission groups, MSM, and PWID from 2008-2018. Top left: Rate of 
HIV diagnoses per 100,000 among all transmission categories. 2008-2018. Top right: Cases of HIV diagnoses 




The Centers for Disease Control and Prevention (CDC) attributes the slowed rate 
of decrease in new HIV infections to a failure in providing prevention and treatment 
services to the most at risk, hard-to-reach populations, as exemplified by the increase in 
new HIV cases among PWID.9 Only 37% of the CDC’s Division of HIV/AIDS 
Prevention’s annual budget of $325 million is allocated for MSM and PWID combined.10 
One study created a robust model to inform how this budget could be optimized and 
reallocated to appropriately address at-risk populations, which the study defined as 15 
subgroups structured by gender, race/ethnicity, and three HIV transmission groups 
(MSM, PWID, high-risk heterosexuals). Based on the model, they recommend that 72% 
of the total annual budget be allocated toward MSM and PWID, rather than just 37%.10 
The study also suggests that resource allocation be continuously optimized based on 
current and future epidemic trends.  
Misallocation of resources also extends into the research arena, where global 
investment in HIV prevention R&D is not appropriately targeted toward prevention in 
key populations. A study found that out of $281 million spent globally on HIV 
prevention research (e.g. product development, clinical trials, community education, 
policy advocacy), only $8.7 million was allocated to MSM, $3.5 million to transgender 
individuals, $1.8 million to PWID, and $0.6 million to male sex workers. The authors 
concluded that prevention research funds are not sufficiently channeled toward 
understanding the complex biological risk, preferences, and social determinants that 
affect populations most at risk for HIV acquisition.11 Further, some of the hardest-to-
reach populations at risk for HIV acquisition are not allocated anything. In our study, we 
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focus on the population of MSM-PWID, which experiences multiple, overlapping HIV 
risks and social vulnerabilities and yet remains understudied and excluded from many 
programmatic and advocacy efforts.  
Quantitative data on MSM-PWID, though scarce, suggest that risk from 
overlapping injection and sexual behaviors are elevated due to unique vulnerabilities 
faced by this population. For example, among both MSM and PWID, experiences of 
stigma in healthcare settings have been well-documented and remain an important barrier 
to preventative care utilization including HIV testing and discussions surrounding HIV 
prevention strategies such as antiretroviral pre-exposure prophylaxis (PrEP).12–17 In 2017, 
29% of MSM and 42% of PWID reported no HIV testing in the past 12 months.7 More 
targeted efforts to increase testing among these groups would reduce delays in diagnosis 
and represent missed opportunities for engagement in care. Furthermore, knowledge of 
PrEP is low among PWID, and recently published studies document the potential benefits 
of improved PrEP implementation in this community.18–20 No studies to our knowledge 
have assessed PrEP awareness or acceptability among MSM-PWID. One quarter of HIV 
care providers reported having prescribed PrEP, most commonly for MSM and rarely for 
PWID.21 MSM-PWID, however, may not be forthcoming about their sexual orientation 
or same-sex sexual behaviors due to anticipated stigma, likely inhibiting effective 
communication with providers and posing an additional barrier to prevention service 
utilization despite overlapping risks from co-occurring injection and sexual behavior.22 
Importantly, behaviors should not be conflated with individuals’ self-described 
identities when designing HIV prevention strategies. In terms of sexual orientation, 
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several studies have shown that MSM choose to identify in a variety of ways (e.g. gay, 
bisexual, heterosexual, “down low,” etc.), especially in Black and Latino communities.23–
26 Strong identification with the gay community, however, is associated with decreased 
risk for HIV, likely due to highly visible prevention efforts in the LGBTQIA+ 
community.27 Similarly, injection behavior is not synonymous with injection-related 
identity. Many individuals engaging in injection behavior will not label themselves a 
“person who injects drugs” or an “injection drug user” if they do not identify with their 
perceived connotations of these terms.28,29 
Traditional HIV prevention strategies do not address this nuance in either MSM 
or PWID communities. A survey of 100 men who have sex with men and also inject 
drugs conducted in Denver, Colorado exemplified these points well, with participants 
stating “I’m not homosexual, I’m not heterosexual, I’m not bisexual. I’m sexual”; “How 
do I tell my wife and baby I’m going to a gay group?”; and “I’m not a junkie, I don’t do 
heroin.”28 Because MSM-PWID often lack strong connections with both groups, an 
urgent need exists to further research this population so that more targeted interventions 
may be developed and oversimplification of behaviors in this community may be 
avoided. 
No qualitative studies to our knowledge have explored the unique HIV risks or 
PrEP-related attitudes of MSM-PWID, highlighting the significance of our research. We 
thus sought to explore the complex interface between MSM and PWID identities in the 
context of HIV acquisition among a sample from urban and non-urban areas of 
Massachusetts and Rhode Island. In Massachusetts, HIV diagnoses in PWID decreased 
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91% from 2000-201430, consistent with national trends that largely resulted from 
healthcare reform and the increasing availability of syringe service programs (SSPs).31 
Rhode Island had similar success after SSPs became available in in 1994, leading to a 
drop in injection-related cases with less than 6 cases reported each year from 2009-
2014.32 Starting in 2015, however, renewed concern arose about the risk faced by PWID. 
From 2015-18, injection-related HIV outbreaks in Lawrence and Lowell, two cities in 
northeastern Massachusetts, demonstrated that transmission was shifting back to PWID 
and increasingly occurring in this population.3,33,34 Our study on MSM-PWID adds to a 
growing body of  literature aiming to understand the experiences and risk environments 
of subgroups35–38 among the community of PWID, with the goal of creating a more 






Despite growing research and biomedical advances in HIV prevention, the annual 
number of new HIV diagnoses nationally has begun to increase among PWID, suggesting 
an urgent need for change in our HIV prevention strategies. Several studies have 
documented the increased risk that men who have sex with men face, and a growing body 
of research demonstrates the particular risks faced by people who inject drugs. Very little 
research, however, seeks to understand the complex intersectional identity and unique 
risks faced by MSM-PWID, beyond a two-pronged approach that separately targets 
sexual and injection behavior that increase HIV acquisition risk. This paper seeks to 
identify unique themes in behaviors that increase risk of HIV acquisition; perception of 
HIV risk; and knowledge, acceptability, and feasibility of PrEP among MSM-PWID in 
urban and non-urban areas of Massachusetts and Rhode Island by conducting a 









Study Design and Sample 
This analysis drew from two qualitative studies that aimed to learn more about the 
experiences of PWID in the context of increasing public health concerns surrounding 
substance use in the U.S. Northeast.33,39,40 The first study (2016-17) recruited and 
interviewed participants in Boston, MA and Providence, RI, whereas the second study 
(2018-19) focused on recruitment from 14 smaller towns across Massachusetts and 
Rhode Island. Participants in both studies were recruited from community-based 
organizations (CBOs) after being introduced to the study by staff at each CBO. Research 
personnel screened interested participants against the inclusion criteria: ≥18 years of age, 
past-month injection of any drug, and self-reported HIV-negative status. Purposive 
sampling methods were also used by research staff to ensure that a diverse subset of 
PWID were included in the sample in terms of age, gender, and substance-use and sexual 
risk behaviors.41,42 Participants provided verbal informed consent, completed a 45- to 60-
minute study session in a private location at each CBO, and were compensated with $25. 
Institutional Review Boards at both Boston University and Brown University approved 
all study protocols and instruments.  
 
Data Collection 
Research staff, trained in all aspects of the study’s data collection, administered a 
brief quantitative survey to participants, followed by a longer qualitative interview. The 
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quantitative survey collected data about each participant’s sociodemographic 
characteristics (e.g., age, sex, gender, sexual orientation), behaviors that increase risk of 
HIV acquisition, and knowledge and likelihood of using PrEP. The qualitative interview 
lasted approximately 45 minutes and consisted of semi-structured, open-ended questions 
about behaviors that increase risk of HIV acquisition, HIV risk perception, and attitudes 
toward PrEP. Sample questions included “Can you tell me about how you or others you 
know inject drugs?”; “Are any of the people you use drugs with also your sexual 
partners?”; “What are the health concerns most important to you right now?”; and 




Data collection continued until thematic saturation was reached, as determined 
during weekly study staff meetings. Development of a qualitative codebook occurred 
using a documented method20 after all team members reviewed interview transcripts to 
create preliminary codes and codebooks. Codes were tested by individual team members, 
discussed to compare and identify areas of discrepancy, and ultimately revised to create 
the final codebook. The final codebook was tested two times to identify and address any 
additional discrepancies. Finalized codes were applied to all transcribed data in NVivo 




For this analysis, nine participants were selected from the overall sample by 
reviewing results of the quantitative survey for self-identified non-heterosexual men. We 
also reviewed qualitative data to identify non-heterosexual sexual behaviors. Full 
transcripts for each participant were analyzed in detail in order to fully contextualize the 
data, allowing us to understand their identities and behaviors in more nuanced ways. We 
then more specifically identified risk behaviors, perceived risk of HIV, and attitudes 
toward PrEP, paying special attention to codes including “Description of Injection 
Behaviors and Practices,” “Sexual Behaviors,” “Sex Work (formal, informal),” “Lack of 
relationships/isolation,” “LGBTQA+ Topics,” “PrEP,” and “Perceived Risk of Negative 
Health Outcomes.”  Findings are illustrated using representative quotes with pseudonyms 
for each participant. Pseudonyms were assigned by research staff to each participant, 
paying attention to findings from documented methods of name assignment.43 Results 






Participant Characteristics from Quantitative Survey 
Among 9 MSM-PWID, age ranged from 25-59 years old. 6 participants identified 
their race as White. The remaining 3 participants identified as Black or African 
American, American Indian or Alaskan Native, or both. All participants were assigned 
male at birth and self-identified as male during quantitative data collection. 7 participants 
identified as bisexual, 1 as homosexual or gay, and 1 as other. 3 participants completed 
less than high school; 1 completed some high school; 2 completed high school or GED; 2 
completed some college; and 1 completed college. 6 participants were unemployed, 1 
employed part-time (less than 30 hours per week), and 2 employed full-time (30+ hours 





Table 1: Participant Characteristics. Socio-demographic factors among participants were collected in a brief quantitative 
instrument administered prior to each interview.  Relevant data are shown here and include age, race, gender (M=male), sex 
(M=male), sexual orientation, highest level of education completed, and employment status (part time defined as less than 30 
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instru ent ad inistered prior to each interview. Relevant data is shown here and includes age, race, gender (M=male), sex 
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Robert 42 White M M Homosexual 
or Gay 




Anthony 29 White M M Bisexual Less than high 
school 
Unemployed 
Marc 48 Black or African 
American 
M M Bisexual Some college Unemployed 
Elan 36 American Indian or 
Alaska Native 
M M Bisexual Less than high 
school 
Unemployed 
Daryl 59 American Indian or 
Alaska Native; 
Black or African 
American 
M M Bisexual Completed high 
school or GED 
Unemployed 
James 25 White M M Bisexual Completed college Employed full-
time 
Gray 37 White M M Bisexual Some high school Unemployed 
Casey 40 White M M Bisexual Completed high 
school or GED 
Unemployed 




Overview of Qualitative Results 
Sexual orientation and gender identity were explored to provide context, when 
available, about participants’ responses to the quantitative instrument (Table 1). 
Behaviors that increase risk of HIV transmission were broken into four categories: 
syringe sharing, inconsistent condom use, sex work, and sex parties. Next, HIV risk 
perception was reported and explored in the context of these behaviors. Although every 
participant engaged in at least one of these behaviors, they did not always have a 
correspondingly high perception of HIV risk. Knowledge, acceptability and feasibility of 
antiretroviral pre-exposure prophylaxis (PrEP), a preventative medication for HIV, was 
reported among the sample and described in the context of not only HIV risk, but also 
factors such as medical mistrust, use of services, and other potential barriers. 
 
Sexual Orientation and Gender Identity 
Participants identified and expressed their sexual orientation, sexual behaviors, 
and gender identity in a variety of ways. Robert identified as gay and described attraction 
toward men. He also identified as a cisgender man on the quantitative instrument, but 
then described his gender identity with more nuance during the qualitative interview, 
stating “I dress as a girl. I feel much more comfortable as a girl. I do it more realistically, 
where you can’t tell I’m a guy and that I have an Adam’s apple. In a way, I’m happy 
being a man but I’m more on the feminine side.”  
Marc identified as a cisgender, bisexual man on the quantitative instrument, and 
went on to describe sexual engagement with men in the context of sex work in the 
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qualitative interview. He also described the degree to which he was open and comfortable 
about his bisexuality: “I don’t want the wrong person walking through the door, saying 
oh, he's here, he gay? You know what I mean? I’m not gay, I’m just bisexual, instead.” 
Casey similarly identified as a cisgender, bisexual man on the quantitative instrument, 
and later described sex work with men. At the time of the interview, he had a primary 
female partner who also engaged in sex work with men.  
Elan and Gray both identified as cisgender, bisexual men and described same-sex 
behavior in the qualitative interview. Elan discussed “having sex with numerous guys” in 
the context of PrEP’s utility. Gray also described having multiple male partners, largely 
in the context of sex parties.  
Anthony, Daryl, and James all identified as cisgender, bisexual men on the 
quantitative instrument, but same-sex behavior did not come up in the qualitative 
interviews. Stephen identified as a cisgender man and described his sexual orientation as 
“Other” on the quantitative instrument. He had a primary female partner and two kids, 




Most participants engaged in injection and sexual behaviors that increase risk of 
HIV transmission, including syringe sharing, inconsistent condom use, sex work, and sex 





Almost all participants engaged in syringe sharing. Early in interviews, some 
participants stated that they did not share syringes with others, though these individuals 
later described specific situations in which they shared. These situations varied in nature, 
but often revolved around a feeling of desperation, especially when experiencing 
withdrawal. Some participants explained that after reusing their only needle so many 
times that the dull tip became too painful or dangerous, they would consider sharing 
sharper needles from their peers. Casey described when he might find himself in this 
situation: 
“Instead of walkin’ 20 minutes to go somewhere, I can just say, you know what? 
Fuck it. Just go upstairs and sometimes it hurts ‘cause the needle will be dull. But 
usually when it’s that time, the next time I will get brand new ones. Or I’ll ask my 
roommates if they have some that are a little better than mine, you know? Yeah, but 
that’s when I might share one of theirs that they have used, you know?” 
Gray similarly described obtaining needles from friends in order to avoid causing 
physical trauma when his only needle was too old: 
“I was just using the same dirty needle for a long time. I went to Boston for a 
couple days and I brought that [needle] back with me over here and just hammered 
myself until it frickin’ broke. It was broken in my skin…so I just get them off my 
friends.” 
For others, however, sharing was a more common practice, especially with their partners 
or friends. There was a common perception that limiting syringe sharing to only one 
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other person, or among a trusted group of individuals, was sufficient to avoid HIV 
acquisition. Casey initially said that he only shared with his partner, but upon further 
probing, said he also shares with "two roommates and another couple." Most participants 
acknowledged that syringe sharing was a practice that might place them at risk for HIV 
acquisition, indicating a desire to move away from it. However, many said they were 
unable to imagine a world in which they could stop sharing syringes completely. Stephen 
conversely said he never shared syringes, and instead purchased syringes as needed from 
the store, from friends, or from his dealer: 
“I’ve gotten them from Walmart a couple of times, they usually don’t give you 
too much trouble. I’ve gotten them from Walgreens, I got them [from] friends, 
from dealers.” 
Some participants demonstrated their understanding and concern of the risk involved 
with syringe sharing and participated in altruistic practices to encourage peers to stop 
sharing. Robert would distribute clean needles amongst his peers when possible, going as 
far as bringing clean needles to the sex parties he attended. Stephen would always refuse 
to distribute his used needles, even amongst close friends, knowing that this could put 
them in danger of acquiring HIV and hepatitis C virus: 
“I don’t want to give mine to anybody…I’ll use mine a couple of times and get rid 
of it. And I’ll give you a new one if you want one, but, no, I’m not gonna give you 
mine.” 
 
Inconsistent Condom Use 
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Many participants reported inconsistent condom use when engaging in anal or 
vaginal intercourse with their partner, regardless of the partner’s sex or gender. Marc, 
however, described condom use with his female partner but not his male partner: “I had a 
girlfriend and we used a condom. Then I went with a guy one time without a condom.” 
Most acknowledged that their low condom use could increase their risk of HIV 
acquisition but did not always alter their practices in response. Anthony did not comment 
on his condom use with male partners, but described never using condoms with his 
female partner with whom he also shared syringes, introducing multiple potential 
pathways for HIV transmission: 
“Never, never, never ever put a condom with that girl on. I don’t think I did one 
time. I was like fuck condoms, yo’…I never used a condom I don’t think, never 
once.” 
Other participants inconsistently used condoms. These participants acknowledged the 
importance of condom use and demonstrated a concerted effort to use condoms when 
possible. Casey, who had a primary female partner but had sex with men in the context of 
sex work, stated "I try to protect myself as much as possible, but there's been times that I 
haven't used condoms.” Some participants identified specific situations in which condom 
use was either impossible or felt unwarranted. These situations ranged in nature. For 
instance, during sex work, condom use was considered more important but did not take 
precedence over immediate physical safety. In other situations, sex with a consistent 
partner, even when the relationship was not perceived as being completely monogamous, 
felt safe enough for participants to forego using condoms. This is exemplified by Marc, a 
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man who had a female partner but exchanged sex with other men, and who also identified 
frequent injection of drugs prior to sex: 
“I don’t use condoms…this girl I’d been having sex with for a while, I haven’t been 
using a condom with her in the last two three months. And, with the AIDS test, I 
don’t have nothing, so [it’s] kind of a risk, not [using a condom].” 
While most participants still acknowledged the importance of using condoms, Stephen 
preferred the sensation of condomless sex. Early in the interview, he stated that his wife 
was his only partner, but later described having sex with others in secret, often in the 
context of substance use. He acknowledged the risk of using condoms inconsistently, but 
had low concerns for HIV acquisition that he could not articulate:  
“I usually don’t use condoms, so yeah, you’re always at risk. You know you’re at 
risk for the whole gamut, and it’s stupid, but I do it anyway just because it feels 
better…I don’t know. I’m not worried about it for some reason.” 
Robert initially said he always used condoms for anal intercourse, but later in the 
interview described no condom use when attending "bareback parties," which he 
described as gay sex parties in which drug use was common.  
“They call them bareback parties. They don’t want to use condoms. I don’t 
understand. I’ve been at these parties before and I’m saying, ‘Hey, I don’t want to 
get sick’ but they just laugh. And if you’re at the parties, you got to do what you 
got to do. It’s all unprotected, a lot of it’s unprotected. When I'm with regular 





Seven participants described current or past engagement in sex work, often for 
money, drugs, food, or shelter. Marc explained his sex work with other men for money: 
“Sometimes I have to go sell my ass. Sometimes I’ll be with other guys to get 
money. I used to go over to the arcade. That’s where all the guys go and I just go 
on in. Just trick for money…And I’d go buy my drugs.” 
While sex work was a common practice for some, others only engaged in it when they 
lacked money for drugs or were desperately trying to avoid withdrawal symptoms. Casey 
had a female partner but described exchanging sex for money with men when 
experiencing withdrawal:  
“If we're sick, you have to do something. So we have people that will come pay 
money for sex or something. I'll leave the room or she [partner] will leave the room 
and they pay for the services and that's it. I have a couple guys that'll come see me 
that really pay a lot of money, so you know.” 
For some participants, sex work was also an unsafe environment in which they would 
forego safety or harm reduction practices. For instance, when asked if he inquired about 
the HIV status of his clients, Robert responded, “You can’t even bring that up. You can’t. 
That’s a conversation you wouldn’t bring up in a situation like that.” Early in the 
interview, Robert stated that he started sex work at the age of 16. Later, he explained how 
this was the same age when he left home after disclosing his sexual orientation to his 
family: “I left home when I was 16 years old. I came out of the closet, I lived with a 
Jewish-Italian family, God, it's a little rough.” For Robert, rejection from family members 
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due to his sexual orientation created the context for his engagement in sex work as a 
survival practice. He also described presenting as both a man and a woman in his current 
sex work. Regarding presenting as a woman, he said “it’s like it’s a mask, it’s a disguise, 
like you could never tell who I am.” Presenting as a woman not only added comfort for 
him, but also served as a tool to conduct sex work without being identified.  
 
Sex parties 
Distinct from sex work, a smaller number of participants described frequenting 
group sex parties with men. According to participants’ descriptions, these parties 
involved large groups of men engaging in mostly anonymous sex. Participants also 
described both syringe sharing and low condom use with men in the context of these 
parties, which combined sex and drugs, most commonly methamphetamine (by injection) 
and “liquid G” (GHB). Robert explained that, in his experience, low condom use was not 
only the preference among individuals at these “bareback parties,” but also heavily 
discouraged across the whole group. Because many of the injection and sexual behaviors 
described above would co-occur, these sex parties pose a unique and very high risk for 
HIV transmission. When describing sex parties, Gray said: 
“We used to have big sex parties and stuff like that. And crystal 
[methamphetamine] and G [GHB] used to be big. I’ve overdosed on liquid G like 
four times, five times…Yeah, it was bad. I mean, that’s when I started using PEP 
[post-exposure prophylaxis] because a lot of times I wouldn’t pay attention, or I’d 
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forget what pin [syringe] was mine ‘cause you would leave your stuff out all over 
the place [and] forget, you know?” 
Reasons for attending sex parties varied. Interestingly, although Gray participated in sex 
parties, he would also host his own parties for a unique purpose—to steal money and 
drugs without engaging in any intercourse: 
“There’s a big gay scene [in Boston]. I became a kind of escort thing through a 
friend of mine, and we used to throw these big hotel parties. My friend would knock 
everybody out and take all their money. It’s kind of horrible. So, that was part of the 
scene, I guess. We would do crystal [methamphetamine], we would have 
[GHB]…A lot of lawyers and doctors and stuff [came] from different cities and out 
of town. And [we would] set up hotel parties and we would have everything set up 
for them and he knew just the right amount just to knock them out. And then he’d 
use one of us as a scapegoat who could take off minutes later and they’d wake up 
and [he’d be] like, ‘Yeah, he took off with all your money,’ you know? And play it 
off." 
Robert discussed attending sex parties to obtain drugs, which made him feel “stronger,” 
but later explained that the parties also gave him a sense of acceptance and belonging in 
the gay community, which helped address his sense of insecurity. He also reluctantly 
engaged in condomless sex—which, as noted previously, he identified as the norm at 
these parties—even if other individuals were HIV-positive: 
“And even if they were sick [HIV-positive] at this party, I’d still go. Just to get 
high. I'm worried about catching something. I don’t want to catch [HIV]. I’ve lost 
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too many friends to it, but I just want to get high and feel better and be part of 
something…I know I'm not anything to write home about. I’m aware of what's 
going on. A lot of times I play stupid because I don’t want people to see the real 
[me]…I don’t really find any people down here, friend-wise, or like someone that 
you can actually say is your friend. 
Robert’s description of feeling isolated and desiring inclusion is consistent with the idea 
that MSM-PWID may not feel well-accepted among any community, causing unique 
vulnerabilities in both their livelihood and our ability to reach them to provide much-
needed preventative and mental health care. 
 
HIV Risk Perception 
In this sample, despite the large proportion of participants who reported engaging in 
behaviors that increase risk of HIV transmission (e.g., syringe sharing, inconsistent 
condom use, sex work and sex parties), personal HIV risk perceptions were not high or 
well-aligned with behaviors. For instance, Anthony described syringe sharing and no 
condom use, but said he viewed his HIV risk as "probably pretty low, probably real low.” 
Anthony also elaborated that his risk was low “as of right now,” introducing the idea that 
perception of HIV risk could change over time. James similarly touched on this idea, 
saying multiple times that his risk was not high “yet” and that he did not need to access 
services “yet.” He also described relying on using drugs with a trusted group of 
individuals because he “knows they’re usually good,” but did not elaborate on how he 
knew this, or what “good” meant: 
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“My biggest risk factor is probably just sharing the wrong needle, or not paying 
attention, and just going with somebody that obviously has HIV or could possibly 
contract it very easily, and just basically letting my guard down. Thankfully it 
hasn’t reached that point yet, knock on wood. You just kinda have to watch out, I 
guess, and just kinda know who you're with. That’s why I have a very selective 
group of people that I usually use [drugs] with, ‘cause I know that they're usually 
good.” 
Other participants also explained that, although they considered themselves at high risk 
for acquiring HIV, they did not consider themselves to be at the highest risk. Casey, 
along with some other participants, appeared more comfortable pointing to peers who 
were engaging in even higher risk practices: 
“People that sell their bodies, prostitutes, male and female, and intravenous drug 
users, those people are [at highest risk]. Other people too, but those are the people 
that are mostly high risk. Sure, somebody else, [if] they're having sex with a few 
partners here and there, yeah, they're at risk, but they're not that [high risk].” 
This sentiment was not the case for everyone. Robert engaged in syringe sharing and did 
not consistently use condoms at sex parties or during sex work, and did consider himself 
to be at high risk of contracting HIV due to these practices. He went on to note that most 
men who had sex with men and injected drugs like him held very low, and often 
inaccurate HIV risk perceptions: 
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“Gay guys are just like, ‘Oh, who cares?’ I don’t understand, like, I’ve been at these 
[sex] parties before and I’m saying, ‘Hey, I don’t want to get sick’ but they just 
laugh. And if you’re at the parties, you got to do what you got to do.” 
Daryl described how his perception of risk changed alongside his use of drugs. He 
explained that he took much greater chances while using drugs, and that he would not 
take these chances otherwise:  
“Yes, [I’m] worried about [getting STIs or HIV] a lot.  You care about yourself 
[when you’re sober], and when you're drinking and drugging, you don't care about 
yourself at all. You look at the person [and] they look healthy to you. You forget 
about this, you forget about that, and you just roll the dice. It’s like rolling your life 
away.” 
Most participants differentiated between risk from sexual and injection-related behaviors. 
Some participants attributed high personal risk for HIV acquisition to syringe sharing, 
while others were more concerned about sexual risk. A common underlying factor was 
the idea that higher risk correlated with the number of people in each setting, i.e. group 
sex would carry a higher risk than sharing syringes with one person, whereas sharing a 
syringe with multiple people would carry a higher risk than unsafe sex with fewer 
partners. Casey, who said he shared needles with one trusted partner, described high risk 
when engaging in sexual behavior with many people when asked about his biggest risk 
factor for HIV acquisition: 
“I think most likely through sex. Because of the risk when you're playing with a 
lot of people, you know what I mean?” 
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Conversely, Gray, who described using PEP after group sexual encounters, described 
high risk when injecting drugs with many people:  
“I just think that there’s more of a risk with a bunch of people shootin’ up 
together. Because you’re sharing. I’ve shared with so many people and it’s like, 
‘Okay, you’ve got Hep C? Okay, that’s fine, I’ve got Hep C too, don’t worry 
about it.’ You just believe what [people say]. You don’t know how many times 
they did that with other people. So, I’ve taken big chances.” 
Interestingly, Robert described his HIV risk in the context of his sexual orientation. 
Robert, a self-identified gay man who injects drugs, was more worried about risk from 
injection, but thought that most gay men were more concerned sexual risk. This 
demonstrates a potential difference in the risk perception of men who have sex with men 
and inject drugs compared to their peers: 
Interviewer: Do you think people are more worried about getting HIV from 
injecting or sex? 
Robert: Injecting, [but] I think in the gay scene it’s sex. [In] the straight world it’s 
more injecting because they go, “Oh, we’re straight, we’re not going to catch 
anything.” Please, you know? 
Interviewer: So gay men are more worried about sexual risk even though they are 
sharing needles? 
Robert: Yeah, but some of them are [aren’t worried about] either, or they think that 
at these parties everyone has it. Why would you go to a gay party if you’re not sick?  
One for the drugs, two for the drugs. 
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In addition to HIV risk perceptions that were inconsistent with reported behaviors, some 
participants explained that they were not concerned with HIV because they were unable 
to prioritize it in their lives. For example, James identified his primary health concern as 
navigating the day-to-day uncertainties that characterized his life. When probed about his 
health concerns more specifically, he identified his weight as his primary concern. Gray 
identified sharing needles as his primary health concern, but then went on to describe 
why this was not his primary concern overall, resurfacing the theme of isolation in this 
community: 
“It’s a lot going on right now. I’m just trying to stay warm and alive…A lot of 
people have family here and stuff like that. I don’t have any family in this area so 
it’s been really tough on me lately.” 
This explanation emphasizes that, for many, day-to-day survival and meeting basic needs 
took precedence over most matters, including mitigation of HIV risk.  
 
PrEP Knowledge, Acceptability, and Feasibility 
Knowledge of PrEP 
No participants had ever used PrEP, although Gray had used PEP more than once 
after he started attending sex parties in the Boston area. Some participants said they had 
heard of PrEP before the interview but could not go on to explain what it was or how it 
worked when prompted, demonstrating a substantial lack of knowledge about this HIV 
prevention medication. Stephen demonstrates his limited knowledge of PrEP in the 
following interaction:  
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Stephen: I’ve just seen a couple commercials. Just late-night watching TV. I don’t 
even know what channel it was. But, yeah, I’ve seen a couple commercials.  
Interviewer:  So, if someone asked you about PrEP, would you be able to explain 
to them what it is? 
Stephen: Not really, not really, no. 
Robert had heard of PrEP from gay “hookup apps,” but was surprised to learn that 
women could also benefit from it. Two participants had not heard of PrEP at all. When 
asked what he knew about PrEP, Daryl stated “Nothing. I hadn’t heard nothing,” 
demonstrating complete unawareness of it. He also expressed frustration about not having 
heard of PrEP: “How come they don't tell you this stuff?  How come people don't tell 
you? It’s amazing how people don't tell you stuff, you know?” After learning about PrEP 
from the interviewer, he was enthusiastic about the prospect of it, as further described 
below. 
 
Acceptability of PrEP 
After learning more about PrEP, six participants expressed positive attitudes about 
their own willingness to use it. Although some of these participants were initially 
unwilling to use it when surveyed before the qualitative interview (i.e., in response to 
“How likely would you be to use PrEP in the future?” on the brief quantitative 
instrument), four expressed increased interest in trying it after spending some time 
talking with interviewers during the qualitative interviews, as exemplified by Marc: 
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“Yeah. I would like to take [it], because I put myself at high risk, you know? Like 
today I took an AIDS test and it came out negative, but you never know. I might 
just get that bad luck one day. But I think that taking a pill to prevent AIDS...Yeah, 
I wouldn’t mind taking one of them.” 
Similarly, Casey said he was “Undecided” about his likelihood of using PrEP before the 
interview, but thought that PrEP was warranted in someone like himself, noting how it 
could be beneficial:  
“Well, because of the lifestyle that I live today, you never know. I know PrEP isn't 
guaranteed. But if you wear a condom, you take PrEP, and you try to do the 
following things, [your] chances [are lower]. So, rather than just not wearing a 
condom, you're doing two or more things to prevent [HIV]. It's good, you know.” 
Anthony, Elan, and Stephen were uninterested in taking PrEP after discussing it with the 
interviewer, but described scenarios in which their willingness could change. Anthony 
said he would be willing to learn more about PrEP before making a definitive decision, 
indicating that he wanted more information about it: "Yeah, I mean I’m interested in how 
it works, maybe, and I’m open ears. I don’t mind hearing…Yeah, I wouldn’t mind 
hearing about how it works, like what it does exactly." Elan’s disinterest in using PrEP 
related to cost and insurance coverage, and he said he would be interested in PrEP if 
these financial and logistical barriers did not exist. Stephen, who did not share needles or 
use condoms, did not feel he was at high enough risk to warrant taking PrEP. He also 
expressed hesitance about PrEP’s benefit:  
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“I don’t feel I’m that high risk anyway. I don’t see myself taking that every day. 
Something about it feels funny [like] taking a pill for no apparent reason. You 
know, you can practice your safe sex practices and still get HIV…I don’t know, to 
me it seems pointless [to take] a pill every day for what you might not get or you 
might not prevent anyway."  
Participants were also asked if PrEP would be useful for the larger PWID community. 
Seven participants believed that it would be. Elan added that PrEP would be especially 
useful for “trans” individuals and people in the “gay world,” in addition to PWID. James, 
who was initially undecided about his likelihood of using PrEP, later described how PrEP 
would not only provide added safety, but also promote recovery and health in PWID: 
“I think it would be [useful]. It definitely would offer a much safer alternative. And 
if they wanted to go down the road to recovery and get involved to the point of 
getting clean, it would definitely be a healthier and safer of a way of just going 
about that. And you know, like I said, we live in an opiate epidemic. There's a huge 
epidemic, not just with opiates, but just drugs in general. And it’s definitely 
refreshing to know that there are safer alternatives out there and safer ways of 
injecting stuff or putting drugs in your body. So it's just good to know that there's at 
least methods out there that can at least be a little bit healthier.” 
Casey explained that PrEP would be even more useful for PWID engaging in sexual 
behaviors that increase risk of HIV transmission, noting that sex workers in particular do 
not always have the option of using a condom. He also countered the idea that being on 
PrEP would cause an increase in behaviors that increase HIV transmission: 
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“I think it's great, you know, I really do, [especially for] people that are 
promiscuous and people that live on the edge. Now don't get me wrong. Just 
because you're taking a medication, you shouldn't put yourself at more risk. But for 
instance, people that live on the street and they're using a puddle of water and all 
kinds of crazy stuff to get high. I'm not saying [use PrEP] so that you can go out 
and just live recklessly. Plus, it's good to have it for people that [engage in] sexual 
services [when] condoms ain't sufficient enough, so I think it's great.” 
Daryl considered PrEP a life-saving medication, noting that its uptake would stop 
preventable deaths from occurring in PWID. He also tackled the idea of peer-based 
stigma, saying that PrEP would foster respect for HIV-positive individuals and pave the 
way for more serodiscordant relationships. Specifically, when asked why PWID are good 
candidates from PrEP, he stated: 
“Because they wouldn't all die. They wouldn't all catch HIV, like how I feel. I feel 
that they could have sex with more people that have HIV, you know, and they 
could live. We could all start living more normal lives with people that have HIV, 
you know?” 
On the other hand, two participants did not think it would be valuable for most PWID. 
Anthony, for instance, thought that PrEP would only be valuable for people engaging in 
extremely high-risk behavior, which he identified as using “dirty” syringes and frequent, 
condomless anal sex.  
 
Feasibility of PrEP 
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Five participants indicated that they believed that daily adherence to PrEP would 
not be a concern. They also indicated that having a routine would be helpful. Robert, for 
example, was already on antidepressants, and noted that the experience of already having 
to take one daily medication would make it easier to add another. Marc indicated that 
forgetfulness while under the influence of drugs could pose an issue, but was still very 
interested. Stephen explicitly indicated that adherence would be an issue due to a lack of 
interest in attending frequent doctor visits, which he found too inconvenient because he 
does not typically engage in preventative care:  
“That doctor visit every two months is kind of a pain in the ass. I mean I don’t 
normally go to the doctor. For me to go, something’s wrong. The only time I go to 
the doctor is when something’s not right. So, for preventative maintenance it’s 
like…like I said, I keep myself healthy, I’m feeling good, everything’s good, 
everything functions the way it’s supposed to, so I don’t know. To me it’s that 
doctor visit every two months, it would be a pain in the ass.” 
Elan echoed a similar sentiment, stating he preferred to stay away from hospitals unless 
necessary:  
“I know people die in hospitals. That’s why [I don’t go]. Now if you’re ringing 
somebody back to life, that’s different. [But] I’m not just going to go to the 
hospital for nothing.” 
Five participants expressed a preference for injectable PrEP, noting that this would be an 
effective solution to adherence problems. Anthony had no preference between a daily pill 
and an injection. Elan and James believed they would prefer oral over injectable PrEP. 
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Elan cited medical mistrust as his reason for avoiding injections of any kind from other 
people: 
“Oh, no, no, no, no, no, no, no. The only one that sticks me with needles is me 
and my tattoo artist. I’ll stick with the pill. I have a crazy imagination about the 
world…That’s why I don’t like going to hospitals that much.” 
James explained that injectable PrEP would have the potential to cause trauma in 
individuals undergoing substance use recovery: 
“That might bring up bad things in the past. Especially for people who have used 
needles, or have injected stuff in their body, [injectable PrEP] may not be the best 
in terms of bringing about the past and everything.” 
Participants were also asked about their experience with healthcare, and several 
participants expressed hesitance about going to a doctor’s office or hospital for their care. 
Robert described negative experiences with medical staff, saying “They think we’re just 
addicts or fags or druggies or prostitutes and they would just rather we die. They don’t 
think anyone’s going to miss us and that’s not always true, you know?” He also said “a 
lot of times” he does not disclose his drug use and sexual behavior to doctors. This was 
common among many participants. Daryl explained that he would hide his injection 
behavior from his doctor: 
“I don’t let my doctor know that I do drugs because that would change [the] 
whole ball game with her…I think she wouldn’t keep my appointments the [same] 
way. I think she would care less about that. I think that she wouldn’t go the nine 
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yards that she goes out the way for me. I think she would try to throw me in 
rehab, lock the door.” 
While other participants did not cite overtly negative experiences with providers, they did 
express a sense of anxiety or embarrassment around doctors. Marc stated “I get scared, 
you know? I just get worried. I’ve just got a lot of anxiety when I see the doctor.” Gray 
described a similar feeling when he wanted to discuss HIV with a doctor: 
“I had to kind of put my tail between my legs when I went. I didn’t know how 
they were going to look at me coming into the office like, ‘Hey I think I may have 
HIV,’ you know what I mean?” 
Many participants, however, described scenarios that would increase their levels of 
comfort among healthcare staff. Common among them was the idea of non-stigmatizing 
behavior among staff and incorporation of mental health in the visit. Robert stated “I 
need someone good that I can talk to. It’s more than just getting my meds. I want it to be 
physical where you can talk to the person.” He also stated that if the provider could not 
address “psychological” aspects of his care, he would “ask to see a different provider or 
wouldn’t be as open.” His gender identity also played a role in his comfort, as he 
described wanting a female provider: “I feel more comfortable talking to a girl because 
I’m kind of like a girl myself.” Marc similarly wanted mental healthcare, stating a 
preference for a psychiatrist in prescribing medication. Casey described a positive 
experience with staff at a rehabilitation facility where he received both substance use and 
mental health treatment. He elaborated on this important combination at the facility, 
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calling it a “dual diagnosis” center for its role in addressing his psychological needs, and 
contrasting it with other centers that only focus on substance use:  
“They’re more sensitive to you by the way that they talk to you, the way that they 
want the atmosphere to be around people. The staff is more sensitive to your 
needs whereas, you know, at the drug place [center with substance use treatment 
only] sometimes I see people that don't even like their job. They're just doing it 
for a paycheck, you know. So, I believe the people at [center with substance use 
and mental health treatment] are there to help you. I really enjoy--not enjoy--but I 
really prefer [it] than anywhere else. If you're working in one of those places you 
have to have some kind of compassion to help people. It takes a certain person to 
be able to help people like that. I just need the dual diagnosis thing. [It’s] the best 
place I've ever been to.” 
This sentiment indicates a greater need for mental healthcare services in this population 









In this qualitative study, we explored HIV risk perceptions, PrEP knowledge and 
attitudes, and experiences accessing different types of care among men who have sex 
with men and inject drugs. These data, taken as a whole, allow us to further understand 
the HIV risks and prevention needs of this population and highlight mechanisms to 
engage them in preventative care.  
Among our sample, participants had low knowledge of PrEP, but were largely 
enthusiastic after learning about it from interviewers. Even the few participants who 
remained unenthusiastic about PrEP attributed their resistance to an insufficient 
understanding of the medication. Interestingly, we found that some participants who had 
reported hearing of PrEP were later unable to demonstrate a full understanding of the 
medication, including what it is, how it works, or where to get it. This shows that 
quantitative reports of PrEP knowledge are not always accurate, and may overrepresent 
individuals’ knowledge of PrEP. Further, although knowledge of PrEP is suboptimal in 
MSM, data suggest that awareness of PrEP among MSM is slowly increasing.44,45 
Whether MSM-PWID knowledge of PrEP is also increasing remains unclear, raising 
important questions regarding effective dissemination of information among MSM-
PWID. Increasing PrEP knowledge among MSM-PWID is fundamental to bolstering 
HIV prevention efforts in this population, but efforts specifically targeted at MSM-PWID 
have been low or nonexistent. The Centers for Disease Control and Prevention compiles a 
list of evidence-based interventions (EBIs) and best practices to aid varying communities 
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across the United States in HIV prevention. This list, compiled as part of the HIV/AIDS 
Prevention Research Synthesis Project, comprises the “Compendium of Evidence-Based 
Interventions and Best Practices for HIV Prevention,” a commonly cited source for 
implementing HIV prevention interventions at the community level. In this list of fifty-
seven population-specific EBIs, there are no interventions for men who have sex with 
men and inject drugs, reflecting a critical need for development of interventions 
specifically targeted toward this hard-to-reach population.46  
Our study suggests that varying identity related to same-sex behavior among men 
who have sex with men and inject drugs may play a role in shaping HIV risk and 
prevention needs. In our study, participants’ sexual orientation (reported on our 
quantitative instrument) included gay, bisexual, and other, with 78% identifying as 
bisexual. Among those who self-identified as bisexual, there were differing descriptions 
in the qualitative interviews about what this identity entailed: some had sex with men as a 
regular practice, while others only referenced sex with men in the context of their sex 
work. Bisexuality is correlated with not only an increased likelihood of engaging in sex 
work, but also homelessness, unemployment, and secrecy of MSM behaviors, which may 
pose additional barriers in reaching this population.47 Further, a growing amount of 
literature is identifying substance use disparities among bisexual individuals and other 
sexual minorities.48–51 A recent study examining disparities in smoking, heavy episodic 
drinking, marijuana use, illicit drug use, and alcohol/substance use disorder found that 
young gay and lesbian individuals and middle-aged bisexual men had significantly higher 
odds on almost all outcomes, and bisexual women had higher odds across all ages.48 A 
	
 37 
2017 review of all evidence-based literature on bisexual health found strong evidence that 
bisexual individuals are at increased risk for mental health and substance use problems 
compared to their heterosexual or gay/lesbian counterparts.51 Stigma- and discrimination-
related stress were leading contributors to these disparities.  
An in-depth understanding of the ways in which sexual orientation and gender 
identity shape HIV risk and prevention needs among men who have sex with men and 
inject drugs could obtained through further research using a systematic conceptual model. 
For example, the intersectional risk environment framework52 helps contextualize the 
unique issues facing men who have sex with men and inject drugs. This model is an 
extension of the classical risk environment framework to examine how social factors 
interact with one another to produce differential risk.53 Importantly, when injection 
behaviors co-occur with other social determinants, including sexual orientation, the 
resulting intersection occupies a landscape fraught with unique barriers to wellbeing. 
Future research should consider using this framework to determine comprehensive public 
health approaches in MSM-PWID and to better design interventions targeted at this 
community. Because of the nuance in how this population refers to their identity (e.g. 
“down low,” “same gender loving,” or “just messing around on the other team”),47 many 
of our participants may not identify with advertising or marketing campaigns directed at 
LGBTQIA+ individuals or MSM. Future studies should consider a more specialized 
model for collecting data about each individual’s orientation, and innovative methods 




Previous research, for example, has classified substance-using MSM into three 
classes, each with distinct strategies to reduce harm: those who used lay strategies 
(avoiding sharing drug preparation equipment, serosorting when sharing needles or 
having condomless anal sex (CAS), practicing withdrawal when having CAS); those who 
use combined sexual and substance use strategies (avoiding sharing needles, using bleach 
to clean needles and other equipment, and avoiding CAS when using drugs); and those 
who used substance-use strategies rather than sexual strategies.54 By stratifying 
substance-using MSM into these three categories, researchers could better identify trends 
among specific subgroups of MSM, and then more effectively present relevant safety 
practices to each group. Future studies should consider a similar approach with MSM-
PWID to identify specific patterns in harm reduction strategies in order to develop 
appropriate and tailored messaging.  
Sex parties emerged as a unique social environment for many MSM-PWID in our 
sample. Several studies focus on the role of substances, broadly, in MSM-attended sex 
parties.55–59 However, very few studies, none of which are qualitative to our knowledge, 
explicitly or solely examine the role of injected drugs in a group sexual context for MSM. 
Data from our study suggest that this social environment poses disproportionately high 
risks for HIV acquisition due to simultaneous sexual and injection behavior in a context 
where judgment may be impaired. Because men who have sex with men and inject drugs 
have higher odds of sharing syringes compared to their MSM or PWID counterparts—
further evidence that traditional harm reduction messaging is not sufficient in this 
population—sex parties may pose an even more heightened risk.60 However, this reliable 
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and unique social context may also serve as an opportunity to implement harm reduction 
interventions in this otherwise hard-to-reach population. Some cities have established 
drug user committees which use a peer-to-peer delivery model for disseminating 
important harm reduction information, programming, and safe injection kits.61 Another 
example of a successful peer-to-peer delivery model is that for naloxone, the distribution 
of which is encouraged in many cities to prevent overdose deaths.62 A similar model 
could be successfully used to deliver harm reduction materials to MSM-PWID in a sexual 
context. Some of our participants described a propensity for altruistic actions, suggesting 
that this type of intervention may be feasible and well-accepted.  
Lastly, our study elucidated a particular need for mental health services in order to 
address unique vulnerabilities in MSM-PWID. The overlapping identities of MSM-PWID 
may make them more prone to social isolation. Studies have shown that MSM-PWID are 
not well-accepted among the larger gay community and report feeling “othered” by gay 
men who do not inject drugs.63 On the other hand, MSM-PWID may not feel fully 
comfortable among their heterosexual peers who inject drugs, placing them at a stressful 
intersection between these two social groups and potentially causing feelings of isolation 
and exclusion, as evidenced by some of our participants’ accounts. These negative 
feelings can be mitigated by providing access to mental health services in contexts that 
are culturally competent, non-stigmatizing, and unassuming about identity. Based on 
participant views in this study, we would recommend providing mental healthcare not 
only at CBOs, but at all potential health-related access points, and avoiding referrals to 
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any facilities segregated by gender, as homophobia among peers has been reported in 
exclusively male environments. 
There are several limitations of this study. Firstly, our sample includes only nine 
participants. While these qualitative interviews provide important social context about 
MSM-PWID, care should be taken to avoid generalizing the themes of this paper to the 
entire MSM-PWID population or to other populations. The small sample size also limited 
our ability to analyze a more diverse subset of MSM-PWID, most notably in terms of 
race, but also other socio-demographic factors. Secondly, we recruited exclusively from 
CBOs, so the views of individuals not engaged with CBOs are not represented in this 
study. Because MSM-PWID have a lower likelihood of accessing substance use 
treatment64, this is an especially important consideration. Thirdly, qualitative interview 
questions did not primarily target topics related to MSM behavior, resulting in potential 
gaps of information about these participants’ habits as they relate to same-sex behavior. 
Despite these limitations, our analysis is one of the first to provide qualitative 
context about the experiences and vulnerabilities of MSM-PWID, and we lay the 
groundwork for future research with this population. Data from our analysis elucidate 
specific prevention needs for this population by not only illustrating certain behaviors 
that increase their risk of HIV acquisition, but also describing methods to increase their 
initiation with and retention in care—namely, continuing to train staff in destigmatizing 
behavior and providing mental healthcare at any points of access in this population. Low 
knowledge but high enthusiasm of PrEP was an important finding, as understanding the 
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response of MSM-PWID to PrEP remains crucial in increasing access to PrEP as a 
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